Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Immunic Inc (NASDAQ: IMUX)

 
IMUX Technical Analysis
1
As on 13th Feb 2026 IMUX STOCK Price closed @ 0.91 and we RECOMMEND N/A for LONG-TERM with Stoploss of 0.00 & N/A for SHORT-TERM with Stoploss of 0.00 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

IMUXSTOCK Price

Open 1.15 Change Price %
High 1.20 1 Day N/A N/A
Low 0.91 1 Week 0.00 0.00
Close 0.91 1 Month 0.00 0.00
Volume 63658627 1 Year 0.00 0.00
52 Week High 0.00 | 52 Week Low 0.00
 
NASDAQ USA Most Active Stocks
LPTX 2.05 365.91%
AMRS 0.14 100.00%
WBA 11.98 0.50%
NVDA 182.81 %
LMDX 0.02 0.00%
YGMZ 0.02 -66.67%
PLUG 1.89 %
LILM 0.05 0.00%
PONO 1.72 2.38%
TELL 1.00 0.00%
 
NASDAQ USA Top Gainers Stocks
MRIN 3450.00 383233.34%
MRIN 3450.00 383233.34%
SPNS 13950.00 32005.87%
SPNS 13950.00 32005.87%
AMRK 3526.00 11954.70%
AMRK 3526.00 11954.70%
KTRA 6.30 2763.64%
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
 
NASDAQ USA Top Losers Stocks
RELIW 0.00 -100.00%
LEXXW 0.00 -100.00%
ARKOW 0.00 -100.00%
HTOOW 0.00 -100.00%
FPAY 0.01 -94.74%
ZIVOW 0.04 -92.73%
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
SWSSU 1.06 -89.40%
OTRK 0.07 -78.79%
 
 
IMUX
Daily Charts		 IMUX
Intraday Charts		 Whats New @
Bazaartrend		 IMUX
Free Analysis
 
IMUX Important Levels Intraday
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
SUPPORT0.00
 
IMUX Forecast February 2026
Share
4th UP Forecast0
3rd UP Forecast0
2nd UP Forecast0
1st UP Forecast0
1st DOWN Forecast0
2nd DOWN Forecast0
3rd DOWN Forecast0
4th DOWN Forecast0
 
IMUX Weekly Forecast
4th UP Forecast0.00
3rd UP Forecast0.00
2nd UP Forecast0.00
1st UP Forecast0.00
1st DOWN Forecast0.00
2nd DOWN Forecast0.00
3rd DOWN Forecast0.00
4th DOWN Forecast0.00
 
IMUX Forecast2026
4th UP Forecast0
3rd UP Forecast0
2nd UP Forecast0
1st UP Forecast0
1st DOWN Forecast0
2nd DOWN Forecast0
3rd DOWN Forecast0
4th DOWN Forecast0
 
 
IMUX Other Details
Segment EQ
Market Capital 241231968.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
IMUX Address
IMUX
 
IMUX Latest News
 
Your Comments and Response on Immunic Inc
 
IMUX Business Profile
Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and other chronic inflammatory and autoimmune diseases, as well as to treat coronavirus disease. The company is also developing IMU-935, an inverse agonist of ROR?t; and IMU-856 for the restoration of the intestinal barrier function in patients suffering from diseases, such as inflammatory bowel disease, irritable bowel syndrome with diarrhea, immune checkpoint inhibitor induced colitis, and other intestinal barrier function diseases. Immunic, Inc. is headquartered in New York, New York. Address: 1200 Avenue of the Americas, New York, NY, United States, 10036
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service